Primary hypothesis: Losartan at 100 mg for 12 weeks will improve CFTR conductance as measured by NPD in patients on Orkambi therapy. It is expected that compared to placebo, ΔNPD in response to 0 Cl-/isoproterenol will change by more than -4 millivolt (mV) using the most polarized nostril each time.